IN2013MU01113A - - Google Patents

Download PDF

Info

Publication number
IN2013MU01113A
IN2013MU01113A IN1113MU2013A IN2013MU01113A IN 2013MU01113 A IN2013MU01113 A IN 2013MU01113A IN 1113MU2013 A IN1113MU2013 A IN 1113MU2013A IN 2013MU01113 A IN2013MU01113 A IN 2013MU01113A
Authority
IN
India
Prior art keywords
rivaroxaban
preparation
relates
present
Prior art date
Application number
Other languages
English (en)
Inventor
Prabhakar Keshav Shrikant
Shashikant Bhise Sanjay
Harishchandra Kamble Hemant
Chaudhari Ganesh
Subhash Patil Deepak
Reddy Sanikommu Srinivas
Hari Bhushan Kumar
Bhaskar Bhirud Shekhar
Original Assignee
Glenmark Generics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glenmark Generics Ltd filed Critical Glenmark Generics Ltd
Priority to US14/780,138 priority Critical patent/US9663505B2/en
Priority to IN1113MU2013 priority patent/IN2013MU01113A/en
Priority to PCT/IB2014/060028 priority patent/WO2014155259A2/en
Publication of IN2013MU01113A publication Critical patent/IN2013MU01113A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
IN1113MU2013 2013-03-25 2014-03-21 IN2013MU01113A (US07585860-20090908-C00102.png)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US14/780,138 US9663505B2 (en) 2013-03-25 2014-03-21 Process for the preparation of rivaroxaban
IN1113MU2013 IN2013MU01113A (US07585860-20090908-C00102.png) 2013-03-25 2014-03-21
PCT/IB2014/060028 WO2014155259A2 (en) 2013-03-25 2014-03-21 Process for the preparation of rivaroxaban

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1113MU2013 IN2013MU01113A (US07585860-20090908-C00102.png) 2013-03-25 2014-03-21

Publications (1)

Publication Number Publication Date
IN2013MU01113A true IN2013MU01113A (US07585860-20090908-C00102.png) 2015-06-19

Family

ID=51625556

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1113MU2013 IN2013MU01113A (US07585860-20090908-C00102.png) 2013-03-25 2014-03-21

Country Status (3)

Country Link
US (1) US9663505B2 (US07585860-20090908-C00102.png)
IN (1) IN2013MU01113A (US07585860-20090908-C00102.png)
WO (1) WO2014155259A2 (US07585860-20090908-C00102.png)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109553611A (zh) * 2017-09-23 2019-04-02 齐鲁制药有限公司 利伐沙班中间体的制备方法和用途
JP7205529B2 (ja) * 2018-02-26 2023-01-17 住友化学株式会社 オキサゾリジノン化合物の製造方法
CN108546265A (zh) * 2018-06-22 2018-09-18 苏州中联化学制药有限公司 一种利伐沙班中间体的合成方法
CN114105970A (zh) * 2022-01-05 2022-03-01 安徽悦康凯悦制药有限公司 一种利伐沙班的制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19962924A1 (de) * 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
DE10300111A1 (de) 2003-01-07 2004-07-15 Bayer Healthcare Ag Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
DE10342570A1 (de) 2003-09-15 2005-04-14 Bayer Healthcare Ag Verfahren zur Herstellung von 4-(4-Aminophenyl)-3-morpholinon
DE102004002044A1 (de) 2004-01-15 2005-08-04 Bayer Healthcare Ag Herstellverfahren
US7816355B1 (en) 2009-04-28 2010-10-19 Apotex Pharmachem Inc Processes for the preparation of rivaroxaban and intermediates thereof
WO2011012321A1 (en) 2009-07-31 2011-02-03 Krka, D.D., Novo Mesto Processes for crystallization of rivaroxaban
CN102822167A (zh) 2010-01-04 2012-12-12 埃南蒂亚有限公司 用于制备利伐沙班的方法及其中间体
EP2354128A1 (en) 2010-02-10 2011-08-10 Sandoz Ag Method for the preparation of rivaroxaban
EP2388260A1 (de) 2010-05-21 2011-11-23 Archimica GmbH Herstellungsverfahren für einen Inhibitor eines Blutgerinnungsfaktors
US20130253187A1 (en) 2010-09-14 2013-09-26 Medichem, S.A. Process for Determining the Suitability for Distribution of a Batch of Thiophene-2-Carboxamide Derivative
EP2630143B1 (en) 2010-10-18 2017-11-29 Apotex Pharmachem Inc. Processes for the preparation of rivaroxaban and intermediates thereof
ES2395304B1 (es) 2011-05-20 2014-01-16 Interquim, S.A. Procedimiento de obtención de una tiofen-2-carboxamida.
CN102250076A (zh) 2011-05-27 2011-11-23 横店集团家园化工有限公司 一种利伐沙班中间体及利伐沙班的制备方法
CN102250077B (zh) * 2011-06-15 2013-11-13 浙江工业大学 一种利伐沙班中间体及其用于合成利伐沙班的方法
WO2013121436A2 (en) 2012-02-06 2013-08-22 Megafine Pharma (P) Ltd A process for preparation of rivaroxaban and intermediates thereof

Also Published As

Publication number Publication date
US20160052919A1 (en) 2016-02-25
US9663505B2 (en) 2017-05-30
WO2014155259A2 (en) 2014-10-02
WO2014155259A3 (en) 2015-01-29

Similar Documents

Publication Publication Date Title
MX2015016535A (es) Metodo de produccion para tagatosa.
TW201613853A (en) Synthesis of polycyclic-carbamoylpyridone compounds
MX370649B (es) Proceso para la preparacion de teneligliptina.
IN2013MU00848A (US07585860-20090908-C00102.png)
MX345926B (es) Nuevas composiciones, producción de las mismas y uso de las mismas para la producción de poliamidas coladas.
MX2015007518A (es) Metodos para tratar el prurito.
IN2013MU00646A (US07585860-20090908-C00102.png)
IN2014DN09450A (US07585860-20090908-C00102.png)
IN2013MU03641A (US07585860-20090908-C00102.png)
IN2014MU00455A (US07585860-20090908-C00102.png)
IN2014DN08777A (US07585860-20090908-C00102.png)
IN2013MU03070A (US07585860-20090908-C00102.png)
GEP201706626B (en) Synthesis of (s)-nifuratel
IN2014CH00151A (US07585860-20090908-C00102.png)
IN2013MU01113A (US07585860-20090908-C00102.png)
IN2014CH00304A (US07585860-20090908-C00102.png)
IN2014DN10209A (US07585860-20090908-C00102.png)
HUE040536T2 (hu) Eljárás halogén-N,N-dimetilbenzilaminok elõállítására
WO2014118606A3 (en) A novel process for the preparation of silodosin
IN2013MU01290A (US07585860-20090908-C00102.png)
PL2883461T3 (pl) Sposób wytwarzania aktywnej folistatyny
MX2015011881A (es) Proceso para la preparacion de 3,7-dimetilnonan-1-ol.
MX2016002198A (es) Proceso para la preparación de un compuesto.
IN2013MU01219A (US07585860-20090908-C00102.png)
IN2013MU03768A (US07585860-20090908-C00102.png)